期刊
FRONTIERS IN NEUROLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fneur.2019.00908
关键词
adult stem cell; cell therapy; clinical trial; induced pluripotent stem cell; stroke
资金
- Instituto de Salud Carlos III [PI17/0054]
- Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS [RD12/0014]
- Fundacion Mutua Madrilena
- Ministry of Economy and Competitiveness of Spain [SAF2017-84267-R]
- European Union program FEDER
- European Regional Development Fund-ERDF
- MADIA project [732678]
- Miguel Servet Program of Instituto de Salud Carlos III [CP14/00154]
Stroke is the main cause of disability and death in the world within neurological diseases. Despite such a huge impact, enzymatic, and mechanical recanalization are the only treatments available so far for ischemic stroke, but only <20% of patients can benefit from them. The use of stem cells as a possible cell therapy in stroke has been tested for years. The results obtained from these studies, although conflicting or controversial in some aspects, are promising. In the last few years, the recent development of the induced pluripotent stem cells has opened new possibilities to find new cell therapies against stroke. In this review, we will provide an overview of the state of the art of cell therapy in stroke. We will describe the current situation of the most employed stem cells and the use of induced pluripotent stem cells in stroke pathology. We will also present a summary of the different clinical trials that are being carried out or that already have results on the use of stem cells as a potential therapeutic intervention for stroke.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据